Vimarsana
Biggest News Aggregation in the World

Dzintars Gotham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dzintars Gotham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dzintars Gotham Today - Breaking & Trending Today

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again - Vimarsana News

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

(CNN)During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. This time, they're not making the same mistake. Countries around the region are rushing t...

Source: weny.com
Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again - Vimarsana News

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

Merck is seeking US Food and Drug Administration emergency use authorization for the drug Molnupiravir -- and if it's granted, the capsule will become the first oral antiviral treatment against

Source: komu.com
Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again - Vimarsana News

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

Source: kezi.com
US Set to Pay $712 Per Patient for Merck's COVID-19 Pill - Vimarsana News

US Set to Pay $712 Per Patient for Merck's COVID-19 Pill

Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as ...

US government pays Merck $712 for 5-day molnupiravir course that only costs $17.74 to manufacture - Vimarsana News

US government pays Merck $712 for 5-day molnupiravir course that only costs $17.74 to manufacture

According to a report by drug pricing experts at the Harvard School of Public Health (HSPH) and King’s College Hospital in London, a five-day course of molnupiravir only costs $17.74 to produce. [...]